首页> 外国专利> A N. MENINGITIDIS BACTERIUM, MENINGOCOCCAL VESICLE OBTAINED BY CULTURING SAID BACTERIUM AND PHARMACEUTICAL COMPOSITION COMPRISING SAID VESICLE

A N. MENINGITIDIS BACTERIUM, MENINGOCOCCAL VESICLE OBTAINED BY CULTURING SAID BACTERIUM AND PHARMACEUTICAL COMPOSITION COMPRISING SAID VESICLE

机译:N.Meningitidis细菌,通过培养所述细菌和包含所述囊泡的药物组合物获得的Mecinococcal囊泡

摘要

Knockout of the meningococcal mltA homolog gives bacteria that spontaneously release vesicles that are rich in immunogenic outer membrane proteins and that can elicit cross-protective antibody responses with higher bactericidal titres than OMVs prepared by normal production processes. Thus the invention provides a bacterium having a knockout mutation of its mltA gene. The invention also provides a bacterium, wherein the bacterium: (i) has a cell wall that includes peptidoglycan, and (ii) does not express a protein having the lytic transglycosylase activity of MltA protein. The invention also provides compositions comprising vesicles that, during culture of bacteria of the invention, are released into the culture medium.
机译:脑膜炎球菌mltA同源物的敲除产生的细菌可自发释放富含免疫原性外膜蛋白的囊泡,并且与正常生产过程中制备的OMV相比,具有更高的杀菌滴度,可引起交叉保护性抗体应答。因此,本发明提供了一种具有其mltA基因的敲除突变的细菌。本发明还提供了一种细菌,其中所述细菌:(i)具有包括肽聚糖的细胞壁,和(ii)不表达具有MltA蛋白的裂解转糖基酶活性的蛋白。本发明还提供了包含囊泡的组合物,所述囊泡在本发明细菌的培养过程中被释放到培养基中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号